[go: up one dir, main page]

SE9500036D0 - Formulation - Google Patents

Formulation

Info

Publication number
SE9500036D0
SE9500036D0 SE9500036A SE9500036A SE9500036D0 SE 9500036 D0 SE9500036 D0 SE 9500036D0 SE 9500036 A SE9500036 A SE 9500036A SE 9500036 A SE9500036 A SE 9500036A SE 9500036 D0 SE9500036 D0 SE 9500036D0
Authority
SE
Sweden
Prior art keywords
formulation
Prior art date
Application number
SE9500036A
Other languages
English (en)
Inventor
Jack Spira
Lars Widlund
Thomas Oesterberg
Brita Sjoestroem
Marianne Mikaelsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9500036A priority Critical patent/SE9500036D0/sv
Publication of SE9500036D0 publication Critical patent/SE9500036D0/sv
Priority to IL11301095A priority patent/IL113010A0/xx
Priority to IL11301099A priority patent/IL113010A/xx
Priority to TW084102570A priority patent/TW400234B/zh
Priority to AU21560/95A priority patent/AU690666B2/en
Priority to PL95316618A priority patent/PL180282B1/pl
Priority to AT95914669T priority patent/ATE222770T1/de
Priority to CA002186126A priority patent/CA2186126C/en
Priority to EP95914669A priority patent/EP0772452B1/en
Priority to ES95914669T priority patent/ES2182899T3/es
Priority to PCT/SE1995/000348 priority patent/WO1995026750A1/en
Priority to JP52561695A priority patent/JP3939750B2/ja
Priority to DK95914669T priority patent/DK0772452T3/da
Priority to BRPI9507227A priority patent/BRPI9507227B8/pt
Priority to DE69527966T priority patent/DE69527966T2/de
Priority to KR1019960705410A priority patent/KR100373882B1/ko
Priority to US08/716,140 priority patent/US5925739A/en
Priority to HU9602693A priority patent/HU223314B1/hu
Priority to PT95914669T priority patent/PT772452E/pt
Priority to NZ283499A priority patent/NZ283499A/xx
Priority to FI963871A priority patent/FI118171B/sv
Priority to NO19964081A priority patent/NO321139B1/no
Priority to MXPA/A/1996/004455A priority patent/MXPA96004455A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE9500036A 1994-03-31 1995-01-05 Formulation SE9500036D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9500036A SE9500036D0 (sv) 1995-01-05 1995-01-05 Formulation
IL11301095A IL113010A0 (en) 1994-03-31 1995-03-16 Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
IL11301099A IL113010A (en) 1994-03-31 1995-03-16 Pharmaceutical formulation comprising factor viii with an activity of at least 500iu/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
TW084102570A TW400234B (en) 1994-03-31 1995-03-17 Pharmaceutical compositions for subcutaneous, intramuscular or intradermal administration containing coagulation factor VIII or factor IX and additive
NZ283499A NZ283499A (en) 1994-03-31 1995-03-31 Haemophilia medicament; comprises coagulation factor viii or factor ix
PCT/SE1995/000348 WO1995026750A1 (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
BRPI9507227A BRPI9507227B8 (pt) 1994-03-31 1995-03-31 formulação farmacêutica para administração subcutânea, intramuscular ou intradérmica
AT95914669T ATE222770T1 (de) 1994-03-31 1995-03-31 Pharmazeutische zubereitung für die subkutane, intramuskuläre oder intradermale verabreichung von faktor viii
CA002186126A CA2186126C (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
EP95914669A EP0772452B1 (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii
ES95914669T ES2182899T3 (es) 1994-03-31 1995-03-31 Formulacion farmaceutica para la administracion subcutanea, intramuscular o intradermica de factor viii.
AU21560/95A AU690666B2 (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor VIII or factor IX
JP52561695A JP3939750B2 (ja) 1994-03-31 1995-03-31 凝固第ｖｉｉｉ因子の皮下、筋肉内または皮内投与用の製薬調合剤
DK95914669T DK0772452T3 (da) 1994-03-31 1995-03-31 Farmaceutisk formulering til subkutan, intramuskulær eller intradermal administration af faktor VIII
PL95316618A PL180282B1 (pl) 1994-03-31 1995-03-31 Kompozycja farmaceutyczna do podawania podskórnego, domiesniowego lub sródskórnego, do leczenia hemofilii PL PL
DE69527966T DE69527966T2 (de) 1994-03-31 1995-03-31 Pharmazeutische zubereitung für die subkutane, intramuskuläre oder intradermale verabreichung von faktor viii
KR1019960705410A KR100373882B1 (ko) 1994-03-31 1995-03-31 인자ⅷ의피하,근내또는피내투여용약제학적제형
US08/716,140 US5925739A (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous intramuscular or intradermal administration of factor VIII
HU9602693A HU223314B1 (hu) 1994-03-31 1995-03-31 Gyógyászati készítmények VIII. véralvadásfaktor szubkután, intramuszkuláris vagy intradermális adagolására
PT95914669T PT772452E (pt) 1994-03-31 1995-03-31 Formulacao farmaceutica para administracao subcutanea intramuscular ou intradermica de factor viii
NO19964081A NO321139B1 (no) 1994-03-31 1996-09-27 Farmasoytisk preparat egnet for subkutan, intramuskulaer eller intradermal administrering.
FI963871A FI118171B (sv) 1994-03-31 1996-09-27 Farmaceutisk beredning för subkutan, intramuskular eller intradermal administration av faktor VIII
MXPA/A/1996/004455A MXPA96004455A (en) 1994-03-31 1996-09-30 Pharmaceutical formulation for administracionsubcutanea, intramuscular or intradermica of factorviii or factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500036A SE9500036D0 (sv) 1995-01-05 1995-01-05 Formulation

Publications (1)

Publication Number Publication Date
SE9500036D0 true SE9500036D0 (sv) 1995-01-05

Family

ID=20396754

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500036A SE9500036D0 (sv) 1994-03-31 1995-01-05 Formulation

Country Status (2)

Country Link
KR (1) KR100373882B1 (sv)
SE (1) SE9500036D0 (sv)

Also Published As

Publication number Publication date
KR100373882B1 (ko) 2003-08-02
KR970702064A (ko) 1997-05-13

Similar Documents

Publication Publication Date Title
DK1093815T3 (da) Oral 2-methyl-thieno-benzodiazepinformulering
DE69636130D1 (de) Permeatsammelsystem
DE69617955D1 (de) Implantat-verbindemechanismus
DE69612617D1 (de) Chloridunterstützte hydrometallurgische metallextraktion
DE69625472D1 (de) Schraubrohrverbindung
DE69636730D1 (de) Spreizspektrumübertragungssystem
DE69626325D1 (de) Einlegesohle
DE69624969D1 (de) Fahrzeugodometerkorrektursystem
DE69625352D1 (de) Dialysatorhalter
DE69617145D1 (de) Umlenkbeschlagstruktur
DE69620081D1 (de) Doppeltradwindkraftturbine
FI951316L (sv) Peroral formulation
DK0825860T3 (da) Præpart
ATA181095A (de) Probiotisch wirksame formulierung
DE69624734D1 (de) Narkosemittelverdunster
ITMI951395A0 (it) Formulazioni di f-silicone
DE69631378D1 (de) Pestizide formulierung
DE69628526D1 (de) Kraftwagenradspureinstellvorrichtung
EP0837863A4 (en) DISODIUM ALENDRONATE PREPARATIONS
DE69617777D1 (de) Werkzeugpositionskorrigiervorrichtung
DE69629479D1 (de) Bremsbacke
DE69631954D1 (de) Spreizspektrumnachrichtenübertragungssystem
ATE198470T1 (de) Alkenyl-benzoylguanidine
DE69620513D1 (de) Zelluloseesterwundverband
DE69619528D1 (de) Induktor